<DOC>
	<DOCNO>NCT01664936</DOCNO>
	<brief_summary>The purpose study see new way image call Cerenkov luminescence effect use standard clinical PET/CT and/or investigation scan do order capture tumor size . The investigator believe endoscopies surgical procedure could benefit type imaging future . The Cerenkov imaging could use guide surgical resection . The purpose study use Cerenkov light FDG , Iodine-131 tracer sand/or investigational tracer image tumor size head , neck , breast , axillary pelvic region highly sensitive camera . The investigator try see get another picture tumor use Cerenkov light part standard clinical scan therapy .</brief_summary>
	<brief_title>Non-Invasive Cerenkov Luminescence Imaging Lymphoma , Leukemia Metastatic Lymph Nodes</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Participant 18 year age old . Participant schedule standard clinical and/or investigational PET/CT scan 131I therapy within Nuclear Medicine Service Main Hospital . Patients must pathologic lymph node metastasis neck , axillary inguinal area ( need biopsy prove ) either leukemia , lymphoma : , Head Neck cancer ( e.g . tonsillar , nasopharynx , tongue carcinoma , breast cancer melanoma ; lymphoma tonsillar squamous cell carcinoma metastases neck region PET/CT imaging , thyroid cancer thyroid ablation therapy . Any infrequent cancer metastasize nodal metastasis neck , axilla inguinal region cervical lymph node eligible well primary goal image pathological ( i.e . hypermetabolic ) lymph node . Patients hypermetabolic activity uptake neck , axilla , breast inguinal region scan , define visually significant lesion suspicious malignancy nuclear medicine physician trainee . ( We include subset patient normal lymph node screen . This subset patient image negative control study . ) Patients imaged Cerenkov luminescence go require darkened enclosure least 10 minute sit still image acquisition , potentially cover dark cloth case ambient light level remain high ultrasensitive camera . Any condition would prevent exclude patient . There past medical , physiological demographic concern . This include patient skin blemish present dermis tumor , particular interest use technique .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>18F-FDG PET/CT scan</keyword>
	<keyword>131I therapy</keyword>
	<keyword>Cerenkov Luminescence Imaging</keyword>
	<keyword>12-050</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Leukemia</keyword>
	<keyword>Metastatic Lymph Nodes</keyword>
</DOC>